Document is current
Any future updates will be listed below
-
Authors
Garza, Maryam Y.
Williams, Tremaine
Myneni, Sahiti
Fenton, Susan H.
Ounpraseuth, Songthip
Hu, Zhuopei
Lee, Jeannette
Snowden, Jessica
Zozus, Meredith N.
Walden, Anita C.
Simon, Alan E.
McClaskey, Barbara
Sanders, Sarah G.
Beauman, Sandra S.
Ford, Sara R.
Malloch, Lacy
Wilson, Amy
Devlin, Lori A.
Young, Leslie W.
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1TR003107, UL1TR003107)
National Institutes of Health (U24OD024957, UG1OD24942, UG1OD024943, UG1OD024944, UG1OD024946, UG1OD024947, UG1OD024951, UG1OD024954, UG1OD024955, UG1OD030016, and UG1OD00319, U24OD024957, UG1OD24942, UG1OD024943, UG1OD024944, UG1OD024946, UG1OD024947, UG1OD024951, UG1OD024954, UG1OD024955, UG1OD030016, and UG1OD00319, U24OD024957, UG1OD24942, UG1OD024943, UG1OD024944, UG1OD024946, UG1OD024947, UG1OD024951, UG1OD024954, UG1OD024955, UG1OD030016, and UG1OD00319, U24OD024957, UG1OD24942, UG1OD024943, UG1OD024944, UG1OD024946, UG1OD024947, UG1OD024951, UG1OD024954, UG1OD024955, UG1OD030016, and UG1OD00319, U24OD024957, UG1OD24942, UG1OD024943, UG1OD024944, UG1OD024946, UG1OD024947, UG1OD024951, UG1OD024954, UG1OD024955, UG1OD030016, and UG1OD00319, U24OD024957, UG1OD24942, UG1OD024943, UG1OD024944, UG1OD024946, UG1OD024947, UG1OD024951, UG1OD024954, UG1OD024955, UG1OD030016, and UG1OD00319, U24OD024957, UG1OD24942, UG1OD024943, UG1OD024944, UG1OD024946, UG1OD024947, UG1OD024951, UG1OD024954, UG1OD024955, UG1OD030016, and UG1OD00319, U24OD024957, UG1OD24942, UG1OD024943, UG1OD024944, UG1OD024946, UG1OD024947, UG1OD024951, UG1OD024954, UG1OD024955, UG1OD030016, and UG1OD00319, U24OD024957, UG1OD24942, UG1OD024943, UG1OD024944, UG1OD024946, UG1OD024947, UG1OD024951, UG1OD024954, UG1OD024955, UG1OD030016, and UG1OD00319, U24OD024957, UG1OD24942, UG1OD024943, UG1OD024944, UG1OD024946, UG1OD024947, UG1OD024951, UG1OD024954, UG1OD024955, UG1OD030016, and UG1OD00319, U24OD024957, UG1OD24942, UG1OD024943, UG1OD024944, UG1OD024946, UG1OD024947, UG1OD024951, UG1OD024954, UG1OD024955, UG1OD030016, and UG1OD00319, U24OD024957, UG1OD24942, UG1OD024943, UG1OD024944, UG1OD024946, UG1OD024947, UG1OD024951, UG1OD024954, UG1OD024955, UG1OD030016, and UG1OD00319, U24OD024957, UG1OD24942, UG1OD024943, UG1OD024944, UG1OD024946, UG1OD024947, UG1OD024951, UG1OD024954, UG1OD024955, UG1OD030016, and UG1OD00319)
- License Information
-
More Information
Article History
Received: 3 January 2022
Accepted: 28 July 2022
First Online: 15 August 2022
Declarations
:
: The ACT NOW CE Study (parent study; IRB#217689) was reviewed and approved by the University of Arkansas for Medical Sciences (UAMS) Institutional Review Board (IRB). The parent study received a HIPAA waiver, as well as a waiver for informed consent/assent. This ancillary, quality control study received a determination of not human subjects research as defined in 45 CFR 46.102 by the UAMS IRB (IRB#239826) and was determined to be exempt by the University of Texas Health Science Center at Houston (UTHealth) IRB (HSC-SBMI-19–0828). All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests.
